Insta
Gujarat: Bharat Biotech Begins Commercial Roll Out Of Covaxin From New Facility In Ankleshwar
Swarajya Staff
Aug 30, 2021, 08:57 AM | Updated 08:57 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a big boost towards augmenting the production capacity of the nation's first indigenously developed COVID-19 vaccine Covaxin, Hyderabad-based Bharat Biotech has rolled out the first commercial batch from its Chiron Behring Vaccines facility in Gujarat's Ankleshwar, reports Times of India.
With the production having begun at the facility which was built during 2020, supplies will now begin from here in September. It should be noted that the production had begun there in early June itself, before which the team from Bharat Biotech had executed engineering batches to study the equipment functionality at the facility.
The first batch was launched by Union Minister for Health and Family Welfare Mansukh Mandaviya.
Covaxin, along with Covishield has been widely used as a part of the Government's nationwide COVID-19 vaccination programme so far. It has been developed by Dr Krishna Ella-led Bharat Biotech in association with the Indian Council for Medical Research (ICMR) and Pune-based National Institute of Virology.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.